P11. Influence of neuroendocrine tumor differentiation on cell adhesion molecule expression in prostatic carcinoma  by Cuhadaroglu, Ö. et al.
E J C S U P P L E M E N T S 4 ( 2 0 0 6 ) 2 7 –5 3 31(PDAC) were analyzed by QRT-PCR, laser capture microdissection,
DNA microarray analysis, immunoblotting, radioimmunoassay,
immunohistochemistry, cell growth, invasion, scattering, and
adhesion assays.
Results: BSP mRNA was detected in 40.7% of normal, in 80% of
CP and in 86.4% of PDAC samples. The median BSP mRNA levels
were 6.1 and 0.9 and zero copies/ll cDNA in PDAC, CP and nor-
mal pancreatic tissues, respectively. BSP was localized in the
cytoplasm of the tubular complexes of CP and PDAC, and in pan-
creatic cancer cells. Five out of eight pancreatic cancer cell lines
expressed BSP mRNA. Recombinant BSP (rBSP) inhibited Capan-1
and SU8686 pancreatic cancer cell growth, with a maximal effect
of 46.4 ± 12.0% in Capan-1 cells and 45.7 ± 14.5% in SU8686
cells. rBSP decreased the invasion of SU8686 cells by
59.1 ± 11.2% and of Capan-1 cells by 13.3 ± 3.8% (p < 0.05),
whereas it did not affect scattering or adhesion of both cell
lines.
Conclusion: Endogenous BSP expression levels in pancreatic
cancer cells and low to absent BSP expression in the surrounding
stromal tissue elements may indirectly enhance the proliferation
and invasion of pancreatic cancer cells.
doi:10.1016/j.ejcsup.2006.04.070
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Background: Neuroendocrine (NE) differentiated tumor cells can
be recurrently found in prostatic carcinoma (PCa). NE tumor are
involved in the proliferation of the surrounding tumor cells by
paracrine mechanisms. The loss of E-cadherin and b-catenin is
a central factor for local invasion and metastasis. To evaluate
the relationship between NE tumor differentiation and the
expression of E-cadherin and b-catenin was correlated with NE
differentiation.
Methods: This study included 102 previously untreated PCa tis-
sue specimens with a low (LNE) or high (HNE) NE differentiation.
The intensity and cellular localization of E-cadherin and b-cate-
nin was evaluated by immunohistochemistry. A homogeneous
membranous staining in >70% of the tumor cells was regarded
as normal, whereas an altered cellular distribution or heteroge-
neous staining in >30% of the tumor cells was regarded as aber-
rant. The expression of E-cadherin and b-catenin was correlated
with the NE differentiation.
Results: Aberrant expression of E-cadherin and b-catenin was
found in 72.7% and 90.2% of the tumors, respectively. In HNE
tumors aberrant expression was significantly increased com-
pared to LNE tumors (p = 0.010 for E-cadherin and p = 0.016 for
b-catenin). In addition, NE cells of which 78.2% were located at
the invasion front did not express E-cadherin or b-catenin as
demonstrated by comparing serial sections.
Conclusions: Tumors with a HNE differentiation have a sig-
nificantly decreased expression of the cell adhesion mole-
cules E-cadherin and b-catenin which were absent in theNE tumor cells. These results indicate that NE tumor cells
might influence the cell–cell adhesion by paracrine mecha-
nisms and play an important role in tumor progression and
invasiveness.
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Background: Choroidal melanoma is the primary eye cancer in
adults, and displays some features in common with cutaneous
melanoma. MUC18 is an important diagnostic marker of cutane-
ous melanoma, with increased expression in tumors associated
with metastatic potential. However, MUC18 expression in primary
choroidal melanoma and melanocytes remains to be fully inves-
tigated. We examined a series of choroidal melanoma cell lines,
melanocytes, and primary choroidal melanomas, for a possible
association between MUC18 expression and more aggressive
forms of choroidal melanoma.
Methods: MUC18 expression (protein and mRNA) was assessed
in choroidal and metastatic melanoma cell lines using immu-
noblotting and RT-PCR. Sections of whole eyes with mixed
spindle/epithelioid choroidal melanomas (n = 18) were immuno-
labelled using a polyclonal antibody to the extracellular domain
of MUC18 (R&D), and visualised using peroxidase and
VectorRed.
Results: Immunoblotting of lysates from melanoma cells showed
a positive band 113 kDa, and MUC18 mRNA was detected in all
cell lines. Moderate/strong cytoplasmic MUC18 immunolabelling
was seen in 5/18 primary tumors (mixed spindle/epithelioid, <18
months detection to enucleation). MUC18 immunolabelling was
seen on tumor vasculature, and in some cases, on networks/chan-
nels, characteristic of more aggressive tumors. Tumor extracellu-
lar matrix showed MUC18 immunolabelling in some cases.
Conclusions: Melanoma cell lines all expressed MUC18, how-
ever, only some primary choroidal melanomas, mostly with fea-
tures suggesting more aggressive histopathology, expressed
moderate/strong MUC18 immunolabelling. These observations
suggest that MUC18 may play a role in tumor progression in some
cases, and may be an appropriate marker for more aggressive
choroidal melanomas.
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